UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers

Journal of the American College of Cardiology, 2023-01, Vol.81 (1), p.1-12

2023

Volltextzugriff (PDF)

Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy

Journal of the American College of Cardiology, 2021-09, Vol.78 (11), p.1114-1123

2021

Volltextzugriff (PDF)

A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication

Journal of the American College of Cardiology, 2024-05, Vol.83 (21), p.2080-2088

2024

Volltextzugriff (PDF)

Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase

Clinical epidemiology, 2022-01, Vol.14, p.1535-1545

2022

Volltextzugriff (PDF)

Rosuvastatin-Induced Arrest in Progression of Renal Disease

Cardiology, 2004-01, Vol.102 (1), p.52-60

2004

Volltextzugriff (PDF)

Safety of rosuvastatin

The American journal of cardiology, 2004-10, Vol.94 (7), p.882-888

2004

Volltextzugriff (PDF)

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

Proceedings of the National Academy of Sciences - PNAS, 1995-11, Vol.92 (23), p.10663-10667

1995

Volltextzugriff (PDF)

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals

The American journal of cardiology, 2003-03, Vol.91 (5), p.11-17

2003

Volltextzugriff (PDF)

Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels

The American journal of cardiology, 2003-06, Vol.91 (11), p.1304-1310

2003

Volltextzugriff (PDF)

AT1 and AT2 angiotensin receptor gene expression in human heart failure

Circulation (New York, N.Y.), 1997-03, Vol.95 (5), p.1201-1206

1997

Volltextzugriff (PDF)

Pressure-Mediated Oligonucleotide Transfection of Rat and Human Cardiovascular Tissues

Proceedings of the National Academy of Sciences - PNAS, 1999-05, Vol.96 (11), p.6411-6416

1999

Volltextzugriff (PDF)

Lisinopril Versus Hydrochlorothiazide in Obese Hypertensive Patients: A Multicenter Placebo-Controlled Trial

Hypertension (Dallas, Tex. 1979), 1997-07, Vol.30 (1), p.140-145

1997

Volltextzugriff (PDF)

Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate

American journal of hypertension, 1999-08, Vol.12 (8), p.806-814

1999

Volltextzugriff (PDF)

Comparison of Effects of Nisoldipine-Extended Release and Amlodipine in Patients With Systemic Hypertension and Chronic Stable Angina Pectoris

The American journal of cardiology, 2003-02, Vol.91 (3), p.274-279

2003

Volltextzugriff (PDF)

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

The American journal of cardiology, 2002-02, Vol.89 (3), p.268-275

2002

Volltextzugriff (PDF)

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial

The American heart journal, 2002-12, Vol.144 (6), p.1036-1043

2002

Volltextzugriff (PDF)

Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia

The American journal of cardiology, 2005-01, Vol.95 (2), p.189-193

2005

Volltextzugriff (PDF)

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial

The American heart journal, 2004-07, Vol.148 (1), p.105-105

2004

Volltextzugriff (PDF)

Modulation of vascular development and injury by angiotensin II

Cardiovascular research, 1999-03, Vol.41 (3), p.689-700

1999

Volltextzugriff (PDF)

Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells

Cardiovascular research, 1997-07, Vol.35 (1), p.158-167

1997

Volltextzugriff (PDF)

Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells

Circulation (New York, N.Y.), 1993-09, Vol.88 (3), p.1190-1195

1993

Volltextzugriff (PDF)

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003

Atherosclerosis. Supplements, 2004-10, Vol.5 (3), p.115-123

2004

Volltextzugriff (PDF)

1084-172 Rosuvastatin is efficacious as monotherapy in patients with combined dyslipidemia

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A480-A480

2004

Volltextzugriff (PDF)

A NEW EUCRYPTODIRAN TURTLE FROM THE LATE CRETACEOUS OF NORTH AMERICA (DINOSAUR PROVINCIAL PARK, ALBERTA, CANADA)

Journal of vertebrate paleontology, 2003-12, Vol.23 (4), p.783-798

2003

Volltextzugriff (PDF)

Familial factors in the antihypertensive response to lisinopril

American journal of hypertension, 2001-03, Vol.14 (3), p.218-223

2001

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(194)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(217)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers

Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy

A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication

Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase

Rosuvastatin-Induced Arrest in Progression of Renal Disease

Safety of rosuvastatin

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals

Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels

AT1 and AT2 angiotensin receptor gene expression in human heart failure

Pressure-Mediated Oligonucleotide Transfection of Rat and Human Cardiovascular Tissues

Lisinopril Versus Hydrochlorothiazide in Obese Hypertensive Patients: A Multicenter Placebo-Controlled Trial

Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate

Comparison of Effects of Nisoldipine-Extended Release and Amlodipine in Patients With Systemic Hypertension and Chronic Stable Angina Pectoris

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial

Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial

Modulation of vascular development and injury by angiotensin II

Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells

Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003

1084-172 Rosuvastatin is efficacious as monotherapy in patients with combined dyslipidemia

A NEW EUCRYPTODIRAN TURTLE FROM THE LATE CRETACEOUS OF NORTH AMERICA (DINOSAUR PROVINCIAL PARK, ALBERTA, CANADA)

Familial factors in the antihypertensive response to lisinopril

Suchergebnisse filtern